Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
Department of Endoscopy Center, China-Japan Union Hospital of JiLin University, Changchun, Jilin, P.R.China.
Expert Rev Mol Diagn. 2022 Aug;22(8):i-xiii. doi: 10.1080/14737159.2022.2012157.
Statement of RetractionWe, the Editors and Publisher of the journal , have retracted the following article:Sen Hong, Zhenkun Yan, YuMei Song, MiaoMiao Bi & Shiquan Li. Down-regulation of lncRNA FEZF1-AS1 mediates regulatory T cell differentiation and further blocks immune escape in colon cancer. Expert Review of Molecular Diagnostics. 2021. DOI: 10.1080/14737159.2022.2012157Since publication, significant concerns have been raised about the integrity of the data and reported results in the article. When approached for an explanation, the authors did not provide their original data or any necessary supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as 'Retracted'.
撤稿声明
我们，期刊的编辑和出版商，已经撤回了以下文章：
Sen Hong、Zhenkun Yan、YuMei Song、MiaoMiao Bi 和 Shiquan Li。lncRNA FEZF1-AS1 的下调介导调节性 T 细胞分化，并进一步阻断结肠癌的免疫逃逸。《分子诊断学专家评论》。2021. DOI: 10.1080/14737159.2022.2012157
自发表以来，人们对该文章的数据和报告结果的完整性提出了严重质疑。当要求作者解释时，他们没有提供原始数据或任何必要的支持信息。由于验证已发表工作的有效性是学术记录完整性的核心，因此我们撤回了这篇文章。已通知本文的通讯作者。
我们在决策过程中参考了我们的出版道德和诚信政策以及 COPE 关于撤稿的指南。
被撤稿的文章将继续在线以保持学术记录，但每页都会被数字水印标记为“撤稿”。
